TNFRSF17 and AL amyloidosis: This paper provides a historical overview of AL amyloidosis treatment, discusses BCMA as an immunotherapy target, reviews current data on CAR-T use in AL amyloidosis, and compares its efficacy and tolerability to that in RRMM.